GENE ONLINE|News &
Opinion
Blog

2026-04-02|

Compass Gold Begins Shallow Drilling Program at Massala Project in Mali to Evaluate Near-Surface Gold

by GOAI
Share To

Compass Gold has initiated a shallow drilling program at its Massala project in Mali, according to an announcement made on April 2, 2026. The program aims to evaluate near-surface gold mineralization across several high-priority targets identified during earlier exploration activities. This marks the latest phase of the company’s ongoing efforts to assess the potential of its extensive land holdings in the region.

The drilling initiative will focus on testing anomalies and structures that were previously highlighted through geochemical sampling and geophysical surveys. The company plans to conduct a series of shallow reverse circulation (RC) drill holes designed to confirm the presence and extent of gold mineralization near the surface. Officials stated that this approach aligns with their strategy of systematically advancing exploration projects while minimizing costs. Further updates regarding progress and results are expected as drilling operations proceed.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: April 2, 2026

©www.geneonline.com All rights reserved. Collaborate with us: [email protected]
Author
Related Post
LATEST
[Illustrations] The Diversity Deficit in Oncology Trials: When Enrollment Logic No Longer Reflects Real-World Patients
2026-04-16
Japanese Researchers Identify Stem Cell Dynamics in Vocal Fold Tissue Maintenance and Repair
2026-04-16
Study Identifies Active Role of Skin Cells in Rabies Virus Replication and Transmission
2026-04-16
Contractor Fatality Halts Operations at ATEX Resources’ Valeriano Project in Chile
2026-04-15
Dual Inhibition of xCT and GGCT Induces Ferroptosis in Glioblastoma Cells
2026-04-15
Researchers Develop Method to Convert Ketones into Saturated Heterocycles for Pharmaceutical Applications
2026-04-15
Naturally Occurring Compounds Luteolin, Naringenin, and Scutellarin Identified as Potential Inhibitors of Breast Cancer-Linked Enzymes HDAC4 and HDAC8
2026-04-15
Scroll to Top